JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
MVCHX
Price
$34.24
Change
-$0.17 (-0.49%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs MVCHX

Header iconJVMTX vs MVCHX Comparison
Open Charts JVMTX vs MVCHXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
MFS Mid Cap Value R3
Price$34.24
Change-$0.17 (-0.49%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs MVCHX Comparison Chart
Loading...
VS
JVMTX vs. MVCHX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and MVCHX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. MVCHX (17.8B). MVCHX pays higher dividends than JVMTX: MVCHX (1.19) vs JVMTX (0.73). JVMTX was incepted earlier than MVCHX: JVMTX (11 years) vs MVCHX (19 years). JVMTX is a more actively managed with annual turnover of: 41.00 vs. MVCHX (19.00). JVMTX (0) and MVCHX (0) have matching initial minimum investment requirements. MVCHX annual gain was more profitable for investors over the last year : 25.36 vs. JVMTX (19.27). MVCHX return over 5 years is better than : 53.02 vs. JVMTX (43.64).
JVMTXMVCHXJVMTX / MVCHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years19 years-
Gain YTD11.01015.36472%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B17.8B131%
Annual Yield % from dividends0.731.1961%
Returns for 1 year19.2725.3676%
Returns for 3 years13.3818.7871%
Returns for 5 years43.6453.0282%
Returns for 10 years63.3482.9976%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems